{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:19:09Z","timestamp":1791537549675,"version":"4.3.4"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2019,4,2]]},"DOI":"10.1001\/jama.2019.0692","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T16:52:51Z","timestamp":1552668771000},"page":"1275","source":"Crossref","is-referenced-by-count":588,"title":["Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation"],"prefix":"10.1001","volume":"321","author":[{"given":"Daniel B.","family":"Mark","sequence":"first","affiliation":[{"name":"Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Anstrom","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubin","family":"Sheng","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Piccini","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaula N.","family":"Baloch","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi H.","family":"Monahan","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie R.","family":"Daniels","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristram D.","family":"Bahnson","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne E.","family":"Poole","sequence":"additional","affiliation":[{"name":"University of Washington Medical Center, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry L.","family":"Lee","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Packer","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the CABANA Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"joi190009r1","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/01.CIR.95.3.572","article-title":"A focal source of atrial fibrillation treated by discrete radiofrequency ablation.","volume":"95","author":"Ja\u00efs","year":"1997","journal-title":"Circulation"},{"issue":"12","key":"joi190009r2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/jce.1994.5.issue-12","article-title":"Successful catheter ablation of atrial fibrillation.","volume":"5","author":"Ha\u00efssaguerre","year":"1994","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"17","key":"joi190009r3","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1056\/NEJMoa1113566","article-title":"Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.","volume":"367","author":"Cosedis Nielsen","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"joi190009r4","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/jama.2014.467","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.","volume":"311","author":"Morillo","year":"2014","journal-title":"JAMA"},{"issue":"21","key":"joi190009r5","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.","volume":"293","author":"Wazni","year":"2005","journal-title":"JAMA"},{"issue":"9","key":"joi190009r6","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1056\/NEJMoa050955","article-title":"Circumferential pulmonary-vein ablation for chronic atrial fibrillation.","volume":"354","author":"Oral","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"joi190009r7","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/j.jacc.2006.08.037","article-title":"A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.","volume":"48","author":"Pappone","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"joi190009r8","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.jacc.2010.01.040","article-title":"Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect.","volume":"55","author":"Wokhlu","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"joi190009r9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/jama.2009.2029","article-title":"Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.","volume":"303","author":"Wilber","year":"2010","journal-title":"JAMA"},{"issue":"5","key":"joi190009r10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nrcardio.2016.10","article-title":"Assessing quality-of-life outcomes in cardiovascular clinical research.","volume":"13","author":"Mark","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"joi190009r11","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","author":"Packer","journal-title":"JAMA"},{"key":"joi190009r12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ahj.2018.02.015","article-title":"Catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation (CABANA) trial: study rationale and design.","volume":"199","author":"Packer","year":"2018","journal-title":"Am Heart J"},{"issue":"1","key":"joi190009r13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/CIRCEP.110.958033","article-title":"Development and validation of the atrial fibrillation effect on quality-of-life (AFEQT) questionnaire in patients with atrial fibrillation.","volume":"4","author":"Spertus","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"suppl 2","key":"joi190009r14","first-page":"A130","article-title":"Clinically important difference in the atrial fibrillation effect on quality-of-life (AFEQT) score: results from the ORBIT-AF registry.","volume":"9","author":"Simon","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"joi190009r15","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1161\/01.CIR.94.7.1585","article-title":"Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias.","volume":"94","author":"Bubien","year":"1996","journal-title":"Circulation"},{"issue":"10","key":"joi190009r16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/0002-9149(89)90496-7","article-title":"A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index).","volume":"64","author":"Hlatky","year":"1989","journal-title":"Am J Cardiol"},{"issue":"6","key":"joi190009r17","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1067\/mhj.2002.122518","article-title":"Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation.","volume":"143","author":"Dorian","year":"2002","journal-title":"Am Heart J"},{"issue":"3","key":"joi190009r19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2014a new facility for the measurement of health-related quality of life.","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"issue":"1","key":"joi190009r20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00043764-200201000-00004","article-title":"Stanford presenteeism scale: health status and employee productivity.","volume":"44","author":"Koopman","year":"2002","journal-title":"J Occup Environ Med"},{"issue":"5","key":"joi190009r21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument.","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"joi190009r22","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1001\/jamacardio.2016.3312","article-title":"Understanding the role of P values and hypothesis tests in clinical research.","volume":"1","author":"Mark","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"7132","key":"joi190009r23","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1136\/bmj.316.7132.690","article-title":"Interpreting treatment effects in randomised trials.","volume":"316","author":"Guyatt","year":"1998","journal-title":"BMJ"},{"issue":"1","key":"joi190009r24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/2168479015622667","article-title":"Interpreting change in scores on patient-reported outcome instruments.","volume":"50","author":"Coon","year":"2016","journal-title":"Ther Innov Regul Sci"},{"key":"joi190009r18","volume-title":"SF-36 Health Survey: Manual & Interpretation Guide","author":"Ware","year":"1993"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jama\/article-pdf\/321\/13\/1275\/17673176\/jama_mark_2019_oi_190009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T23:45:13Z","timestamp":1606779913000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2019.0692"}},"subtitle":["The CABANA Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":24,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019,4,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2019.0692","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735328399.793558687","asserted-by":"object"}]},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,2]]}}}